Our study investigated the possible molecular mechanisms of berberine (BBR) in the treatment of the liver inflammatory response in the livers of rats with high-fat diet-induced NAFLD via the Angptl2 pathway. This evidence concerns the gene ANGPTL2 and metabolic dysfunction-associated steatotic liver disease.